NMPA Approval

Ranibizumab Injections

Approval Number

国药准字SJ20181010

Registration Date

November 17, 2022

Previous Approval Numbers

S20181010

Drug Information

Generic Name

雷珠单抗注射液

Trade Name

诺适得

Dosage Form

注射剂

Strength

10mg/ml，每支装量0.165ml

Drug Type

生物制品

Registration Date

November 17, 2022

Expiry Date

November 16, 2027

Company Address

6343 Risch, Switzerland

Company Address

Eisenbahnstrasse 2-4, 88085 Langenargen, Germany

Empowering clinical research with data-driven insights and AI-powered tools.

雷珠单抗注射液 - NMPA 批准文号 | MedPath